Burden of VKC in the US: A Retrospective Claims Database Analysis

Euna B Koo,Tiffany M Yu,Andrew J Layton,Steven Babineaux,Simon Fung,Euna B. Koo,Tiffany M. Yu,Andrew J. Layton

DOI: https://doi.org/10.1016/j.ophtha.2024.01.038

IF: 14.277

2024-02-01

Ophthalmology

Abstract:In this claims analysis, vernal keratoconjunctivitis (VKC) patients (≤18 years) treated with immunomodulators or corticosteroids had more corneal complications and higher ophthalmic care costs versus matched non-VKC controls, indicating a need for more effective treatments.

ophthalmology